Amphastar Pharms Inc Drug Patent Portfolio

Amphastar Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amphastar Pharms Inc News

Amphastar Pharmaceuticals Reports Q3 Earnings for Generic Pharmaceuticals (NASDAQ: AMPH)

12 Nov, 2025

Q2 Earnings Summary: Viatris (NASDAQ:VTRS) and Other Generic Pharmaceutical Companies

20 Aug, 2025

FTC Reinstates Efforts to Address Incorrect Patent Listings in Order to Tackle Elevated Drug Costs

26 May, 2025

FTC Intensifies Efforts to Eliminate Invalid Drug Patents Hindering Generic Medications - NTD News

21 May, 2025

See More